Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Patient-specific 3D-printed Resorbable Scaffolds of Polycaprolactone, Beta-tricalcium Phosphate, and Metformin Used for Maxillary Bone Regeneration: Randomized Clinical Trial

NCT06773923 is registered in ClinicalTrials.gov with Universidad Austral de Chile as lead sponsor.

NCT NCT06773923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06773923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Patient-specific 3D-printed Resorbable Scaffolds of Polycaprolactone, Beta-tricalcium Phosphate, and Metformin Used for Maxillary Bone Regeneration: Randomized Clinical Trial
Lead sponsor
Universidad Austral de Chile
Phase
Phase 3
Overall status
Enrolling by invitation
Start date
July 1, 2024
Completion date
December 1, 2025
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone loss, bone loss, age related, edentulous mouth, jaw fractures, jaw, edentulous